Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion type Assertion NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_head.
- NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion description "[Here, we analyzed in preneoplastic and neoplastic livers from Fisher 344 and Brown Norway rats, possessing different genetic predisposition to HCC, in transforming growth factor-alpha (TGF-alpha) and c-Myc-TGF-alpha transgenic mice, characterized by different susceptibility to HCC, and in human HCC: (i) iNOS function and interactions with nuclear factor-kB (NF-kB) and Ha-RAS/extracellular signal-regulated kinase (ERK) during hepatocarcinogenesis; (ii) influence of genetic predisposition to liver cancer on these pathways and role of these cascades in determining a susceptible or resistant phenotype and (iii) iNOS prognostic value in human HCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_provenance.
- NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion evidence source_evidence_literature NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_provenance.
- NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion SIO_000772 18579559 NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_provenance.
- NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion wasDerivedFrom befree-20150227 NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_provenance.
- NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_assertion wasGeneratedBy ECO_0000203 NP731432.RAcyyz0S6ZpVtfJ_P9iGN1N2G8yepLZ-UeAHUHDB0Ye_g130_provenance.